Thyroid Metastases from Hepatocellular Carcinoma after Liver Transplantation
Hepatocellular carcinoma (HCC) patients with metastases to the thyroid are extremely rare. A patient who underwent liver transplantation for HCC recurrence had metastatic thyroid recurrence detected 4 years later. A literature review identified six documented cases, analyzing relevant data on HCC wi...
| Autores: | , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2024 |
| País: | Brasil |
| Institución: | Associação Brasileira de Transplante de Órgãos (ABTO) |
| Repositorio: | Brazilian Journal of Transplantation |
| Idioma: | inglés portugués |
| OAI Identifier: | oai:ojs3.emnuvens.com.br:article/584 |
| Acceso en línea: | https://bjt.emnuvens.com.br/revista/article/view/584 |
| Access Level: | acceso abierto |
| Palabra clave: | Carcinoma Hepatocelular Metástase Neoplástica Neoplasias da Glândula Tireoide Hepatocellular Carcinoma Neoplasm Metastasis Thyroid Neoplasms |
| Sumario: | Hepatocellular carcinoma (HCC) patients with metastases to the thyroid are extremely rare. A patient who underwent liver transplantation for HCC recurrence had metastatic thyroid recurrence detected 4 years later. A literature review identified six documented cases, analyzing relevant data on HCC with thyroid metastasis following liver transplantation. There is a prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) as etiologies of liver disease (83.3%), with alpha-fetoprotein (AFP) levels elevated in five cases. Additionally, the time between the diagnosis of HCC and thyroid metastasis was within 3 years. The patient remains clinically stable in outpatient follow-up, with an 8-month current survival after total thyroidectomy. |
|---|